WS5 - Biomarkers
Work Strand 5 focuses on serum biomarkers
Published research suggests there are a large number of biological factors predictive of Hepatitis C treatment outcome or disease progression.
The objective of this Work Strand is to generate serum biomarker datasets associated with treatment response and cirrhosis progression.
This Work Strand is led by Professor Will Irving (University of Nottingham).